Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancerKUZEL, Timothy M; KIES, Merrill S; WU, Nini et al.Cancer investigation. 2002, Vol 20, Num 5-6, pp 634-643, issn 0735-7907Article

Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancerMASTERS, Gregory A; HAHN, Elizabeth A; SHEVRIN, Daniel H et al.Lung cancer. 2003, Vol 39, Num 2, pp 221-226, issn 0169-5002, 6 p.Article

Radiation-induced xerostomia in patients with head and neck cancer: Pathogenesis, impact on quality of life, and managementCHAMBERS, Mark S; GARDEN, Adam S; KIES, Merrill S et al.Head & neck. 2004, Vol 26, Num 9, pp 796-807, issn 1043-3074, 12 p.Article

Cetuximab in cancers of the lung and head & neckKIM, Edward S; VOKES, Everett E; KIES, Merrill S et al.Seminars in oncology. 2004, Vol 31, Num 1, pp 61-67, issn 0093-7754, 7 p., SUP1Article

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neckLIST, Marcy A; RUTHERFORD, Judith Lee; STRACKS, John et al.Cancer. 2002, Vol 95, Num 1, pp 98-104, issn 0008-543XArticle

Merkel cell carcinoma of the tongue and head and neck oral mucosal sitesYOM, Sue S; ROSENTHAL, David I; EL-NAGGAR, Adel K et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006, Vol 101, Num 6, pp 761-768, issn 1079-2104, 8 p.Article

EFFECT OF INDUCTION CHEMOTHERAPY ON SPEECH AND SWALLOWING FUNCTION IN PATIENTS WITH ORAL TONGUE CANCERBARRINGER, Denise A; HUTCHESON, Katherine A; STURGIS, Erich M et al.Head & neck. 2009, Vol 31, Num 5, pp 611-617, issn 1043-3074, 7 p.Article

Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults : A case seriesSTURGIS, Erich M; MOORE, Brian A; GLISSON, Bonnie S et al.Head & neck. 2005, Vol 27, Num 9, pp 748-756, issn 1043-3074, 9 p.Article

Phase II trial of taxol in salivary gland malignancies (E1394) : A trial of the eastern cooperative oncology groupGILBERT, Jill; YI LI; PINTO, Harlan A et al.Head & neck. 2006, Vol 28, Num 3, pp 197-204, issn 1043-3074, 8 p.Article

Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer : Eastern Cooperative Oncology Group Study PH882HAAS, Naomi B; MANOLA, Judith; HUDES, Gary et al.American journal of clinical oncology. 2000, Vol 23, Num 6, pp 589-592, issn 0277-3732Article

Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234HARARI, Paul M; HARRIS, Jonathan; STRAUBE, William et al.Journal of clinical oncology. 2014, Vol 32, Num 23, pp 2486-2495, issn 0732-183X, 10 p.Article

Epidermal Growth Factor Receptor Inhibitors for Treatment of Orbital Squamous Cell CarcinomaEL-SAWY, Tarek; SABICHI, Anita L; MYERS, Jeffrey N et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 12, pp 1608-1611, issn 0003-9950, 4 p.Article

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialCOHEN, Ezra E. W; HARAF, Daniel J; KIES, Merrill S et al.Journal of clinical oncology. 2006, Vol 24, Num 21, pp 3438-3444, issn 0732-183X, 7 p.Article

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancerARGIRIS, Athanassios; STENSON, Kerstin M; HARAF, Daniel J et al.Head & neck. 2004, Vol 26, Num 5, pp 447-455, issn 1043-3074, 9 p.Article

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancerROSEN, Fred R; HARAF, Daniel J; PELZER, Harold et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1689-1697, issn 1078-0432, 9 p.Article

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: Potential for decreased toxicity and combination with biologic therapyHERBST, Roy S; KHURI, Fadlo R; BLUMENSCHEIN, George JR et al.Cancer. 2002, Vol 95, Num 2, pp 340-353, issn 0008-543X, 14 p.Article

Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell CarcinomaZHONG, Lai-Ping; ZHANG, Chen-Ping; WANG, Li-Zhen et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 744-751, issn 0732-183X, 8 p.Article

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer : Results From a Phase II StudyCOHEN, Ezra E. W; ROSEN, Lee S; TORTORICI, Michael et al.Journal of clinical oncology. 2008, Vol 26, Num 29, pp 4708-4713, issn 0732-183X, 6 p.Article

Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?GARDEN, Adam S; ASPER, Joshua A; MORRISON, William H et al.Cancer. 2004, Vol 100, Num 6, pp 1171-1178, issn 0008-543X, 8 p.Article

Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaPAPADIMITRAKOPOULOU, Vassiliki A; GINSBERG, Lawrence E; LIPPMAN, Scott M et al.Cancer. 2003, Vol 98, Num 10, pp 2214-2223, issn 0008-543X, 10 p.Article

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neckTSAO, Anne S; GARDEN, Adam S; LEWIN, Jan et al.Journal of clinical oncology. 2006, Vol 24, Num 25, pp 4163-4169, issn 0732-183X, 7 p.Article

Differential expression of p63 isotypes (ΔN and TA) in salivary gland neoplasms : biological and diagnostic implicationsMARUYA, Shin-Ichiro; KIES, Merrill S; WILLIAMS, Michelle et al.Human pathology. 2005, Vol 36, Num 7, pp 821-827, issn 0046-8177, 7 p.Article

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane- refractory/resistant nonsmall cell lung carcinomaKIM, Edward S; KIES, Merrill S; TIGHIOUART, Mourad et al.Cancer. 2005, Vol 104, Num 3, pp 561-569, issn 0008-543X, 9 p.Article

Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancerSOCINSKI, Mark A; SCHELL, Michael J; MOORE, Martha et al.Journal of clinical oncology. 2002, Vol 20, Num 5, pp 1335-1343, issn 0732-183XArticle

Phase ii study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neckSHIN, Dong M; GLISSON, Bonnie S; KIES, Merrill S et al.Cancer. 2002, Vol 95, Num 2, pp 322-330, issn 0008-543XArticle